Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats
- 1 December 2001
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 38 (6), 1272-1277
- https://doi.org/10.1161/hy1201.096576
Abstract
The type-2 (AT 2 ) angiotensin (Ang) II receptor has been characterized as potentially counterregulatory to the actions of Ang II at its type-1 (AT 1 ) receptor. We investigated the effects of Ang II and CGP-42112A (CGP), a selective peptide AT 2 receptor agonist, on blood pressure (BP) in rats with or without pharmacological blockade of the AT 1 receptor with losartan (LOS) or valsartan (VAL). In anesthetized rats (n=5 per group) receiving normal sodium intake, Ang II (200 pmol/kg per minute IV) alone increased BP from a control of 112±3 to 168±7 mm Hg ( P P P 2 receptor antagonist PD 123,319 (PD) completely blocked the hypotensive response to LOS combined with Ang II ( P =NS from control). In conscious rats (n=5 per group) receiving normal sodium intake, VAL (10 mg/kg) alone decreased BP from a control of 98±5 to 86±3 mm Hg ( P P P P N G -nitro- l -arginine methyl ester, an inhibitor of NO synthase. The results strongly suggest that the AT 2 receptor induces a systemic vasodilator response mediated by NO that counterbalances the vasoconstrictor action of Ang II at the AT 1 receptor.Keywords
This publication has 11 references indexed in Scilit:
- Induction of angiotensin II subtype 2 receptor-mediated blood pressure regulation in synthetic diet-fed ratsJournal Of Hypertension, 2000
- No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar ratsJournal Of Hypertension, 1999
- Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilationJournal of Clinical Investigation, 1999
- Increased Vasoconstrictor Response of the Mouse Lacking Angiotensin II Type 2 ReceptorBiochemical and Biophysical Research Communications, 1999
- Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.Journal of Clinical Investigation, 1998
- Clinical and Hormonal Effects of the New Angiotensin II Receptor Antagonist LRB081Journal of Cardiovascular Pharmacology, 1996
- Binding of valsartan to mammalian angiotensin AT1 receptorsRegulatory Peptides, 1995
- Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in miceNature, 1995
- Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptorNature, 1995
- Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted ratEuropean Journal of Pharmacology, 1993